Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC

Intraoperative radiotherapy treatment in the Philippines

The importance of training to improve cancer care in the Philippines

PSMO and the future of cancer care in the Philippines

Tumour markers and their role in cancer treatment

The role of curative neoadjuvant treatment in certain cancer types

The pros and cons of breast IORT and ultra hypofractionation (FR)

War in Ukraine: The logistical challenges of transferring medical materials

Choosing Wisely in hemato-medical oncology

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Precision oncology: Present and future in breast cancer

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG